Equites Radar

IRMD · iRadimed Corporation

Medical DevicesUnited StatesAnalyst view: none

$94.49

-0.26% last session

End-of-day data · updated 2026-07-28

Mildly bullish3 bullish · 1 bearish technical signals
To mean target: +24.9%

Market cap

$1B

Enterprise value

$1B

Trailing P/E

52.0

Forward P/E

40.4

Dividend yield

1.0%

Beta

0.91

Avg volume

0M

Employees

0K

2D change

0.62%

5D change

1.30%

10D change

-2.01%

30D change

1.19%

60D change

4.88%

MTD change

-3.02%

YTD change

-1.85%

Analyst Outlook

Consensus rating
Recommendation mean (1–5)
Covering analysts2
Mean price target$118.00
Low price target$116.00
Upside to mean target+24.9%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)49.1
50-day MA$93.83
200-day MA$92.73
Price vs 50-day MA+1.1%
Price vs 200-day MA+2.3%
MACD histogram-0.44
Volume vs 3-month avg0.8×
52w low $55.5552w high $104.87

Analyst sentiment over time — IRMD

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-04-02

Latest call per bank · past 12 months

Recent rating actions

DateFirmActionRatingPrice target
2026-04-02Freedom BrokerInitiatesBuy$0.00 $116

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 49 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 1.1% above the 50-day MA ($93.83).
  • Price vs 200-day MA: Trading 2.3% above the 200-day MA ($92.73).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-0.44) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($55.55) and high ($104.87).

IRMD Price Chart

Loading chart for IRMD

Fundamentals

Revenue (TTM)$0M
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$7.71
Net debt / EBITDA-1.9
WACC10.0%
Revenue growth13.00%
Earnings growth22.00%

About iRadimed Corporation

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

More in Medical Devices

Screen IRMD against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.